Adam B. Shapiro

5.1k total citations
75 papers, 3.8k citations indexed

About

Adam B. Shapiro is a scholar working on Molecular Biology, Molecular Medicine and Oncology. According to data from OpenAlex, Adam B. Shapiro has authored 75 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 26 papers in Molecular Medicine and 23 papers in Oncology. Recurrent topics in Adam B. Shapiro's work include Antibiotic Resistance in Bacteria (26 papers), Drug Transport and Resistance Mechanisms (17 papers) and Antibiotics Pharmacokinetics and Efficacy (17 papers). Adam B. Shapiro is often cited by papers focused on Antibiotic Resistance in Bacteria (26 papers), Drug Transport and Resistance Mechanisms (17 papers) and Antibiotics Pharmacokinetics and Efficacy (17 papers). Adam B. Shapiro collaborates with scholars based in United States, United Kingdom and Canada. Adam B. Shapiro's co-authors include Victor Ling, Ning Gao, Ping Lam, Alita A. Miller, Richard E. McCarty, Peihua Lu, Jack‐Michel Renoir, Fred C. Lam, Peter B. Reiner and Frances J. Sharom and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Analytical Biochemistry.

In The Last Decade

Adam B. Shapiro

74 papers receiving 3.7k citations

Peers

Countries citing papers authored by Adam B. Shapiro

Since Specialization

Citations

This map shows the geographic impact of Adam B. Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam B. Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam B. Shapiro more than expected).

Fields of papers citing papers by Adam B. Shapiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam B. Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam B. Shapiro. The network helps show where Adam B. Shapiro may publish in the future.

Co-authorship network of co-authors of Adam B. Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of Adam B. Shapiro. A scholar is included among the top collaborators of Adam B. Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam B. Shapiro. Adam B. Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Small molecule inhibitors of mannan-binding lectin-associated serine Proteases-2 and-3 2025 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Adam B. Shapiro, Samir H. Moussa, April Chen, Charles J. Eyermann, John P. O’Donnell, Alita A. Miller, (unknown)	0
2	Clinical Outcomes for Patients With Monomicrobial vs Polymicrobial Acinetobacter baumannii-calcoaceticus Complex Infections Treated With Sulbactam-Durlobactam or Colistin: A Subset Analysis From a Phase 3 Clinical Trial 2024 ·Open Forum Infectious Diseases ·Sarah M. McLeod, Alita A. Miller, Khurram Rana, David Altarac, Samir H. Moussa, Adam B. Shapiro	7
3	Molecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates ofAcinetobacter baumannii 2023 ·Antimicrobial Agents and Chemotherapy ·Samir H. Moussa, Adam B. Shapiro, Sarah M. McLeod, Ramkumar Iyer, Nicole Carter, Yu-Kuo Tsai, L. Kristopher Siu, Alita A. Miller	23
4	Bacterial Cytological Profiling Identifies Rhodanine-Containing PAINS Analogs as Specific Inhibitors of Escherichia coli Thymidylate Kinase In Vivo 2021 ·Journal of Bacteriology ·(unknown), (unknown), Joseph Sugie, Eray Enüstün, Adam B. Shapiro, Hannah Tsunemoto, Alan I. Derman, Kit Pogliano, Joe Pogliano	11
5	Target-Based Resistance in Pseudomonas aeruginosa and Escherichia coli to NBTI 5463, a Novel Bacterial Type II Topoisomerase Inhibitor 2014 ·Antimicrobial Agents and Chemotherapy ·Asha S. Nayar, Thomas J. Dougherty, Folkert Reck, Jason Thresher, Ning Gao, Adam B. Shapiro, David E. Ehmann	21
6	The Role of a Novel Auxiliary Pocket in Bacterial Phenylalanyl-tRNA Synthetase Druggability 2014 ·Journal of Biological Chemistry ·(unknown), Andrew D. Ferguson, Paul Fleming, Ning Gao, Laurel Hajec, Jun Hu, (unknown), David C. McKinney, Sarah M. McLeod, D. Bryan Prince, Adam B. Shapiro, Ed T. Buurman	25
7	Complete steady-state rate equation for DNA ligase and its use for measuring product kinetic parameters of NAD+-dependent DNA ligase from Haemophilus influenzae 2014 ·BMC Research Notes ·Adam B. Shapiro	5
8	Allosteric inhibition of the DNA-dependent ATPase activity of Escherichia coli DNA gyrase by a representative of a novel class of inhibitors 2012 ·Biochemical Pharmacology ·Adam B. Shapiro, Beth Andrews	13
9	A High-Throughput, Homogeneous, Fluorescence Resonance Energy Transfer-Based Assay for Phospho-N-acetylmuramoyl-pentapeptide Translocase (MraY) 2012 ·SLAS DISCOVERY ·Adam B. Shapiro, Haris Jahić, Ning Gao, Laurel Hajec, (unknown)	24
10	Inhibitors of acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 1: Hit to lead evaluation of a novel arylsulfonamide series 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Andrew R. McKenzie, Adam B. Shapiro, Ludovic R. Otterbein, Haihong Ni, (unknown), S. Stokes, Robert Albert, Sameer Kawatkar, J. Breed	24
11	Time-dependent, reversible, oxaborole inhibition of Escherichia coli leucyl-tRNA synthetase measured with a continuous fluorescence assay 2012 ·Analytical Biochemistry ·Adam B. Shapiro, Ning Gao, Laurel Hajec, David C. McKinney	10
12	High-throughput, homogeneous, fluorescence intensity-based measurement of adenosine diphosphate and other ribonucleoside diphosphates with nanomolar sensitivity 2011 ·Analytical Biochemistry ·Adam B. Shapiro, Laurel Hajec, Ning Gao	5
13	Novel Bacterial NAD ⁺ -Dependent DNA Ligase Inhibitors with Broad-Spectrum Activity and Antibacterial Efficacy In Vivo 2010 ·Antimicrobial Agents and Chemotherapy ·Scott D. Mills, Ann E. Eakin, Ed T. Buurman, Joseph Newman, Ning Gao, Hoan K. Huynh, Kenneth D. Johnson, Sushmita D. Lahiri, Adam B. Shapiro, Grant K. Walkup, Wei Yang, S. Stokes	63
14	A Homogeneous, High-Throughput Fluorescence Anisotropy-Based DNA Supercoiling Assay 2010 ·SLAS DISCOVERY ·Adam B. Shapiro, Haris Jahić, Swati Prasad, David E. Ehmann, Jason Thresher, Ning Gao, Laurel Hajec	24
15	An Integrated Approach to Fragment-Based Lead Generation:Philosophy, Strategy and Case Studies from AstraZenecas Drug Discovery Programmes 2007 ·Current Topics in Medicinal Chemistry ·Jeffrey S. Albert, Niklas Blomberg, Alexander L. Breeze, Alastair Brown, Jeremy N. Burrows, Philip D. Edwards, R.H.A. Folmer, Stefan Geschwindner, Ed Griffen, Peter W. Kenny, Thorsten Nowak, Lise‐Lotte Olsson, Hitesh J. Sanganee, Adam B. Shapiro	91
16	β‐Amyloid efflux mediated by p‐glycoprotein 2001 ·Journal of Neurochemistry ·Fred C. Lam, (unknown), Peihua Lu, Adam B. Shapiro, Jack‐Michel Renoir, Frances J. Sharom, Peter B. Reiner	313
17	Ligand-mediated Tertiary Structure Changes of Reconstituted P-glycoprotein 1999 ·Journal of Biological Chemistry ·(unknown), Catherine Vigano, Adam B. Shapiro, Victor Ling, Jean‐Marie Ruysschaert	84
18	The mechanism of ATP-dependent multidrug transport by P-glycoprotein. 1998 ·PubMed ·Adam B. Shapiro, Victor Ling	70
19	Positively Cooperative Sites for Drug Transport by P‐Glycoprotein with Distinct Drug Specificities 1997 ·European Journal of Biochemistry ·Adam B. Shapiro, Victor Ling	378
20	Using purified P-glycoprotein to understand multidrug resistance 1995 ·Journal of Bioenergetics and Biomembranes ·Adam B. Shapiro, Victor Ling	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact